KENT BARKER questions the logic behind the recommendation to add a chickenpox vaccine to the existing shots for young children.

Was it just a coincidence that, in the week that the Covid enquiry heard evidence about chickenpox parties, the government’s main health advisory body recommended the rollout of a chickenpox vaccine?

The former head of the civil service, Lord Mark Sedwill, later apologised for his suggestion in 2020 that the prime minister should go on TV and explain that it was “like the old days with chickenpox”, where people were going to have chickenpox parties: “The sooner a lot of people get this [Covid] and get it over with the better,” he is reported to have said.

The concept of a ‘chickenpox party’ is simple. Many parents want their child to get varicella, the chickenpox virus, at an early stage and so acquire natural immunity to the disease from then on. The symptoms are a rash that turns into itchy, fluid-filled blisters that eventually turn into scabs. It seldom lasts more than five days, and is considered a relatively minor, if unpleasant, illness in childhood, but more serious when contracted by teenagers or adults. Immunity from varicella also protects against shingles later in life. Shingles – herpes zoster – is produced by the same varicella zoster virus (VZV) that causes chickenpox. But the effects are longer lasting and often considerably more uncomfortable.

ROUTINE VARICELLA VACCINATION 

The Joint Committee on Vaccination and Immunisation (JCVI) has now recommended to the government that a vaccine against varicella should be added to the UK’s routine childhood immunisation programme with two doses, one at 12 and the other at 18 months of age. The JCVI says: “If approved, it would bring the UK into line with other countries offering routine varicella vaccination, including Germany, Canada, Australia and the United States, the latter of which has had a childhood programme in place since 1995”.

- Advertisement -
St Michaels Hospice Run Advert

One might well wonder why? If the vaccination has been standard in the US for more than a quarter of a century, why not in the UK? And if we had good reasons not to follow the Americans, why change now?

In the 28 years the US has had its chickenpox vaccination programme, a large number of studies have been carried out. One (Goldman GS, King PG) found that a universal chickenpox vaccination programme was neither effective nor cost-effective and actually caused a ‘dramatic rise’ in shingles. It also found that the more people were vaccinated, the less effective the vaccine became as it reduced the natural immunity boosts which come from exposure to people shedding the ‘wild’ varicella virus. The wild virus also has been shown to protect against brain tumours (Canniff J, Donson AM et al).

INCREASED RISK OF SHINGLES

Another (Wu PY, Wu HD et al) supported the findings that vaccinating children against chickenpox increases the risk of shingles in teenagers and adults. Conversely, adult exposure to children with chickenpox actually protects them against shingles. While cases of chickenpox did decrease with vaccination, cases of shingles not only increased, but occurred in people who were younger.

As with all public health initiatives, there has to be a cost-benefit analysis. Here, though, the cost is not just the financial one but the possibility of side-effects or adverse reactions. They must be weighed up against the absolute benefits of saving lives. Smallpox, for instance, was such a deadly disease that you had a 30% chance of dying if you contracted it. That’s to say that three people in every 10 who got it did not recover. On the other end of the scale, you are very, very unlikely to die from chickenpox if you get it. 

A recent study – Severe complications of chickenpox in hospitalised children in the UK and Ireland (Cameron JC, , Allan G et al) showed that over a year only 133 (0.8 per 100,000) children needed hospital treatment. Of those, just eight died – and most of them had other underlying conditions.

Now it might be argued that if you could save the lives of eight children by vaccinating the 600,000 who are born in the UK each year, it could be worth it. But would it still be worth it if that meant increasing the risk of shingles in the population? The death rate for shingles is hard to determine, but government data suggests that about 50 people die from it each year – though they tend to be over 70 years old and may well have had other health problems.

Nonetheless, you could read these statistics to suggest that to save 133 children going to hospital with chickenpox where eight might die from complications, you are – according to the US studies – dramatically increasing the likelihood of Shingles which is more likely to be fatal.

SIDE EFFECTS

But it’s not just a question of fatality. Vaccines can have side effects that occasionally cause severe damage to health. 

There are currently 80 people taking legal action against AstraZenica claiming they were injured by the Covid vaccine while 148 people have been awarded payments under the government’s Vaccine Damage Payment Scheme (VDPS). 

AstraZenica said their vaccine had an “acceptable safety profile” and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.”

Few serious side effects to the chickenpox vaccine have been officially reported, but a US vaccine information website – ImmunisationInfo.com – which is certainly not an ‘anti-vax’ site, says: “The chickenpox (varicella) vaccine often causes fevers and a mild chickenpox rash. Very rarely, vaccines against chickenpox can cause serious side effects like seizures or brain reactions.”

EVIDENCE FROM THE USA

So the question remains, why would the UK’s Joint Committee on Vaccination and Immunisation now be recommending a rollout of the chickenpox vaccine given even the remotest possibility of side effects, when the illness itself does such little harm? Add to that the apparently widespread evidence that the vaccine causes an increase in shingles in adolescents and adults which is often more serious than chickenpox in children, and the decision does seem to lack logic. Though Professor Sir Andrew Pollard, Chair of the JCVI, says “We now have decades of evidence from the USA and other countries showing that introducing this programme is safe, effective and will have a really positive impact on the health of young children.”

One further issue is that, according to the British Medical Journal, the plan is to add the varicella vaccine to the existing triple measles, mumps and rubella shots. There has already been some disquiet among parents about lumping those three together. If the prospect of a fourth being tacked on were to further reduce the take up of the MMR, it could well impact on the government’s decision.

Would it be overly cynical to suggest that the main beneficiary of the rollout of a varicella vaccine in the UK would be ‘big pharma’ – who would be selling the NHS an additional million plus doses of its product each year?


We hope you have enjoyed reading this article. The future of our volunteer led, non-profit publication would be far more secure with the aid of a small donation. You can also support local journalism by becoming a friend of HIP. It only takes a minute and we would be very grateful.

- Advertisement -
https://www.hastingsindependentpress.co.uk/wp-content/uploads/2023/11/chickenpox-3-cu-1024x707.jpghttps://www.hastingsindependentpress.co.uk/wp-content/uploads/2023/11/chickenpox-3-cu-150x150.jpgHIPHealth and Environmentchickenpox vaccine,Lord Mark SedwillKENT BARKER questions the logic behind the recommendation to add a chickenpox vaccine to the existing shots for young children. Was it just a coincidence that, in the week that the Covid enquiry heard evidence about chickenpox parties, the government’s main health advisory body recommended the rollout of a chickenpox...The Hastings & St Leonards non-profit community newspaper